top of page
Header by karolina-grabowska-pexels

Test Directory

Cancer Antigen 125



Expected Turnaround

24 hours

This immunoassay is indicated for use as an aid in the detection of residual or recurrent ovarian carcinoma.


Electrochemiluminescence-immunoassay (ECLIA)

Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration.

Gross hemolysis, Gross Lipemia

Refrigerated: 5 days Frozen: 6 months

Cancer Antigen 125; Carbohydrate antigen 125; CA 125; CA125 (Cancer Antigen 125); CA25; Ovarian Cancer-Related Antibodies; Cancer Ag 125 (CA 125), Serum

Serum, gel separator, SST

1 ML

0 - 999


- 38.1

bottom of page